An Exclusively Oral Ribavirin Regimen for Respiratory Syncytial Virus Infection after Lung Transplantation is Effective and Cost-Efficient

L.M. Carlos,F.S. Burrows, M.L. Plit, A.P. Havryk,M. Benzimra, R.F. Pearson,A.R. Glanville,D.R. Darley,C. Thomson,M.A. Malouf

JOURNAL OF HEART AND LUNG TRANSPLANTATION（2020）

引用 0|浏览9

暂无评分

摘要

An exclusively oral regimen of loading and maintenance dose ribavirin for treatment of RSV post LTx appears to be effective and well-tolerated. Furthermore, it carries a significant cost saving and completely avoids hospital admission in 69% of patient episodes.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要